Caris Life Sciences, Inc. (CAI) Price Prediction & ForecastCAIForecastCaris Life Sciences, Inc.

Alphio's CAI stock price prediction model matches the current Caris Life Sciences, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $26.00 (+1.45%). The 1-week path is $25.02 (-2.38%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Caris Life Sciences Inc is a good buy right now due to its recent strong revenue growth and positive market sentiment. The current price is $25.63, and the company's gross margin has improved significantly to 68.10% in Q2 2026, indicating strong profitability potential. Additionally, analysts have set a price target of $30, suggesting a potential upside of 17.5%. However, the main risk is the company's high forward P/E ratio of 60.98, indicating that the stock may be overvalued if growth does not meet expectations.

Caris Life Sciences, Inc. (CAI) last closed at $25.63, losing -2.84%. These facts feed the 1-day and 1-week CAI price prediction above.